Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Uncommon complication following intrathecal chemotherapy
Transient or permanent paraplegia
Initially described following intrathecal methotrexate (MTX) in pediatric acute lymphoblastic leukemia patients
Smooth linear enhancement of conus pia, anterior cauda equina nerve roots
Unenhanced T1W, T2W images normal
Guillain-Barré syndrome
Cerebrospinal fluid (CSF) disseminated metastases
Postradiation radiculopathy
Intrathecal MTX, arabinoside (Ara-C) standard prophylaxis, and treatment agents for pediatric CNS leukemia
MTHFR polymorphism affects folate homeostasis, may modify or predict CNS vulnerability to MTX
Lower extremity flaccid weakness, most often without sensory deficit
↑ CSF protein, mononuclear pleocytosis, CSF immunoglobulin G synthesis
Most commonly occurs after > 1 intrathecal chemotherapy dose
Abnormal electrodiagnostic studies correlate with nerve root enhancement
Most patients are children, but rare reports in adults
Extent of clinical recovery is variable
Correlation with clinical information critical to establishing correct diagnosis
Contrast administration essential to detect cauda equina abnormality
and cauda equina
. The unenhanced images may be normal in patients with anterior lumbar radiculopathy, so contrast should always be given.
and cauda equina
. The diagnosis would have been missed without contrast administration.
.
but not the dorsal cauda equina nerve roots
.
Methotrexate (MTX), cytosine arabinoside (Ara-C)
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here